Trials / Conditions / Age-Related Maculopathies
Age-Related Maculopathies
6 registered clinical trials studyying Age-Related Maculopathies.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration NCT01494805 | Lions Eye Institute, Perth, Western Australia | Phase 1 / Phase 2 |
| Completed | Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Includin NCT01003691 | Pfizer | Phase 1 |
| Completed | Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AM NCT01024998 | Genzyme, a Sanofi Company | Phase 1 |
| Completed | Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration NCT00877032 | Pfizer | Phase 1 |
| Completed | Enhancement of Macular Pigment Density by Oral Lutein Supplementation NCT00563979 | Insel Gruppe AG, University Hospital Bern | N/A |
| Completed | Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration NCT00051129 | Alcon Research | Phase 3 |